The LANL IBC has the responsibility for review and approval of all proposals, activities, and experiments involving an organism or product of an organism that presents a risk to humans. This includes, but is not limited to, work with potential pathogens, work with human clinical samples and primary cell lines and work with DNA from pathogenic organisms. The IBC review is conducted in accordance with guidance and requirements of the Centers for Disease Control and Prevention, the National Institutes of Health and the LANL Biosafety Laboratory Implementation Requirement.
"We invite the public to observe the IBC deliberations to increase understanding of bioscience research," said IBC Chairman Jim Freyer. The IBC membership includes Laboratory staff members, community health care providers and three members of the public not associated with the Laboratory or any work under review.
Members of the public who want more information about the meeting can contact Johnnie Martinez of the Laboratory's Community Relations Office at 667-2194.
Los Alamos National Laboratory, a multidisciplinary research institution engaged in strategic science on behalf of national security, is operated by Los Alamos National Security, LLC, a team composed of Bechtel National, the University of California, The Babcock & Wilcox Company, and Washington Group International for the Department of Energy's National Nuclear Security Administration.
Los Alamos enhances national security by ensuring the safety and reliability of the U.S. nuclear stockpile, developing technologies to reduce threats from weapons of mass destruction, and solving problems related to energy, environment, infrastructure, health, and global security concerns.